APA (7. basım) Alıntı

Zhao, Y., Griesel, R., Omar, Z., Simmons, B., Hill, A., van Zyl, G., . . . Meintjes, G. (2023). Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: A noncomparative, double-blind, randomized placebo-controlled trial. Oxford University Press.

Chicago Style (17. basım) Atıf

Zhao, Y., R. Griesel, Z. Omar, B. Simmons, A. Hill, G. van Zyl, C. Keene, G. Maartens, ve G. Meintjes. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.

MLA (9th ed.) Atıf

Zhao, Y., et al. Initial Supplementary Dose of Dolutegravir in Second-line Antiretroviral Therapy: A Noncomparative, Double-blind, Randomized Placebo-controlled Trial. Oxford University Press, 2023.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..